Skip to main content
SpringerLink
Log in

Controlling Emesis in Patients Receiving Cancer Chemotherapy

  • Conference paper
Supportive Care in Cancer Patients

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 108))

Abstract

Over the past several years, the appropriate use of antiemetics has increased, as has the ability to control chemotherapy-associated nausea and vomiting. With greater use of chemotherapy and with the development of newer agents in which emesis is a major side-effect, the need for improved control of nausea and vomiting has become an important consideration in medical oncology and in supportive care. The primary objective of this paper is to provide a practical guide that discusses some of the major issues in the antiemetic approach to the patient receiving chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kris MG, Tyson LB, Gralla RJ, et al. (1983) Extrapyramidal reactions with high-dose metoclopramide. N Engl J Med 309: 433

    PubMed  CAS  Google Scholar 

  2. Allen JC, Gralla RI, Reilly C et al. (1985) Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 3: 1136–1141

    PubMed  CAS  Google Scholar 

  3. D’Acquisto RW, Tyson LB, Gralla RJ et al. (1986) The influence of a chronic high alcohol intake on chemotherapy-induced nausea and vomiting. Proc Am Soc Clin Oncol 5: 257

    Google Scholar 

  4. Sullivan JR, Leyden MJ, Bell R (1983) Decreased cisplatin induced nausea and vomiting with alcohol ingestion. N Engl J Med 309 (13): 796

    Article  PubMed  CAS  Google Scholar 

  5. Gralla RJ, Braun TJ, Squillante A et al. (1981) Metoclopramide: initial clinical studies of Controlling Emesis in Patients Receiving Cancer Chemotherapy 99 high dosage regimens in cisplatin-induced emesis. In: Poster D (ed) The treatment of nausea and vomiting induced by cancer chemotherapy. Masson, New York, pp 167–176

    Google Scholar 

  6. Fetting JH, Grochow LB, Folstein MF et al. (1982) The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep 66: 1487–1493

    PubMed  CAS  Google Scholar 

  7. Borison HL, McCarthy LE (1983) Neuropharmacology of chemotherapy induced emesis. Drugs 25: 8–17

    Article  PubMed  CAS  Google Scholar 

  8. Meyer BR, Lewin M, Dreyer DE et al. (1984) Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med 100: 393–395

    PubMed  CAS  Google Scholar 

  9. Gralla RJ, Itri LM, Pisko DE et al. (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochloperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305: 905–909

    Article  PubMed  CAS  Google Scholar 

  10. Gralla RJ, Tyson LB, Borden LB et al. (1984) Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol. Cancer Treat Rep 68: 163–172

    PubMed  CAS  Google Scholar 

  11. Frustaci S, Tumolo S, Tirell U et al. (1983) High-dose metoclopramide versus dexamethasone in the prevention of cisplatin induced vomiting. Proc ASCO 2: 87

    Google Scholar 

  12. Aapro MS, Plezia PM, Alberts DS et al. (1983) Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone vs high-dose metoclopramide. Proc. ASCO 2: 93

    Google Scholar 

  13. Grunberg SM, Gala KV, Lampenfeld M et al. (1984) Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. J Clin Oncol 2: 782–787

    PubMed  CAS  Google Scholar 

  14. Richards PD, Raum MA, Batemen M et al. (1986) The antiemetic efficacy of secobarbital and promazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial. Cancer 58: 959–962

    CAS  Google Scholar 

  15. Strum SB, McDermed JE, Opfell RW et al. (1982) Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. JAMA 247: 2683–2686

    CAS  Google Scholar 

  16. Tyson LB, Clark RA, and Gralla RJ (1982) High-dose metoclopramide; control of dacarbazine-induced emesis in a preliminary trial. Cancer Treat Rep 66: 2108

    PubMed  CAS  Google Scholar 

  17. Gralla RI, Tyson LB, Clark RA et al. (1985) An all oral combination antiemetic regimen of patients receiving cytoxan + adriamycin +vincristine (CAV). Proc Am Soc Clin Oncol 4: 267

    Google Scholar 

  18. Anthony LB, Krozely MG, Woodward NJ et al. (1986) Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized double-blind trial. J Clin Oncol 4: 98–103

    PubMed  CAS  Google Scholar 

  19. Garnick MB (1983) Oral metoclopramide and cisplatin chemotherapy. Ann Intern Med 99: 127

    PubMed  CAS  Google Scholar 

  20. Von Hoff DD, Schilsky R, Reichert CM et al. (1979) Toxic effects of cis-dichlorodiamineplatinum ( II) in man. Cancer Treat Rep 63: 1527–1531

    Google Scholar 

  21. Grossman B, Lessin LS, and Cohen P (1979) Droperidol prevents nausea and vomiting from cis-platinum. N Engl J Med 301: 47

    PubMed  CAS  Google Scholar 

  22. Neidhart J, Gayen M, and Metz E (1980) Haldol is an effective antiemetic for platinum and mustard induced vomiting when other agents fail. ProcASCO 21: 365

    Google Scholar 

  23. Wampler G (1983) The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25: 35–51

    Article  PubMed  Google Scholar 

  24. Markman M, Sheidler V, Ettinger DS et al. (1984) Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 311: 549–552

    Article  PubMed  CAS  Google Scholar 

  25. Frytak S, Moertel CG, O’Fallon J et al. (1979) Delta-9-tetrahydrocannabinol as an antiemetic in patients treated with cancer chemotherapy: a double comparison with prochlorperazine and a placebo. Ann Intern Med 91: 825–830

    PubMed  CAS  Google Scholar 

  26. Sallan SE, Cronin CM, Zelen M et al. (1980) Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med 302: 135–138

    Article  PubMed  CAS  Google Scholar 

  27. Orr LE, McKerman JF, Bloone B (1980) Antiemetic effect of tetrahydrocannabinol. Arch Intern Med 140: 1431–1433

    Article  PubMed  CAS  Google Scholar 

  28. Can BI, Bertrand M, Browning S et al. (1985) A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective randomized double-blind study. J Clin Oncol 3: 1127–1132

    Google Scholar 

  29. Aapro MS, and Alberts DS (1981) High-dose dexamethasone for prevention of cisplatinum induced vomiting. Cancer Chemother Pharmacol 7: 11–14

    Article  PubMed  CAS  Google Scholar 

  30. Lee BJ (1981) Methylprednisolone as an antiemetic. N Engl J Med 3034: 486

    Google Scholar 

  31. Cassileth PA, Lusk EJ, Torri S et al. (1983) Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 143: 1347–1349

    Article  PubMed  CAS  Google Scholar 

  32. Kris MG, Gralla RJ, Tyson LB et al. (1985) Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of methoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer 55: 527–534

    Article  PubMed  CAS  Google Scholar 

  33. Kris M, Clark R, Gralla R et al. (1986) Randomized double-blind antiemetic (AE) trial comparing combinations of metoclopramide, dexamethasone and lorazepam (MDL) in 120 patients (PTS) receiving cisplatin (DDP). Proc Am Soc Clin Oncol 5: 251

    Google Scholar 

  34. Laszlo J, Clark RA, Hanson DC et al. (1985) Lorazepam in cancer patients treated with cisplatin: a drug with antiemetic amnestic and anxiolytic effects. J Clin Oncol 3: 864–869

    PubMed  CAS  Google Scholar 

  35. Vincent BJ, McQuistion DJ, Einhorn LH et al. (1983) Review of cannabinoids and their antiemetic effectiveness. Drugs 25: 52–62

    Article  PubMed  Google Scholar 

  36. Tyson LB, Gralla RI, Clark RA et al. (1985) Phase I trial of levonantradol in chemotherapy-induced emesis. Am J Clin Oncol 8: 528–532

    Article  PubMed  CAS  Google Scholar 

  37. Herman TS, Einhorn LH and Jones SE (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 300: 1295–1297

    Article  PubMed  CAS  Google Scholar 

  38. Steele N, Gralla RJ, Braun DW Jr (1980) Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis. Cancer Treat Rep 64: 219–224

    PubMed  CAS  Google Scholar 

  39. Chang AE, Shiling DJ, Stillman RC et al. (1979) Delta-9-tetrahydrocannabinol as an antiemetic in patients receiving high-dose methotrexate: a prospective randomized evaluation. Ann Intern Med 91: 819–824

    PubMed  CAS  Google Scholar 

  40. Venner P, Bruera E, Drebit D et al. (1986) Intensive treatment scheduling of nabilone (N) plus dexamethasone (DM) vs. methoclopramide (M) plus DM in cisplatinum (CP)-induced emesis. Proc Am Soc Clin Oncol. 5: 253

    Google Scholar 

  41. Allan SG, Cornbleet MA, Warrington PS et al. (1984) Dexamethasone and high-dose metoclopramide: efficacy in controlling cisplatin-induced nausea and vomiting. Br Med J 289: 878–879

    Article  CAS  Google Scholar 

  42. Rosell R, Abad-Esteve A, Ribas-Mundo M et al. (1985) Evaluation of a combination antiemetic regimen including IV high-dose metoclopramide, dexamethasone, and diphenhydramine in cisplatin-based chemotherapy regimens. Cancer Treat Rep 69: 909–910

    PubMed  CAS  Google Scholar 

  43. Roila F, Tonato M, Basurto C et al. (1986) Antiemetic activity of high doses of metoclopramide (MTC) combined with methylprednisolone (P) vs. MTh alone in cisplatin treated cancer patients (PTS). A randomized double blind trial of the Italian Oncology Group for Clinical Research ( GOIRC ). Proc Am Soc Clin Oncol 5: 263

    Google Scholar 

  44. Mason BA, Dambra J, Grossman B et al. (1982) Effective control of cisplatin-induced nausea using high-dose steroids and droperidol. Cancer Treat Rep 66: 243–245

    PubMed  CAS  Google Scholar 

  45. Wilcox PM, Fetting JH, Nettesheim KM et al. (1982) Anticipatory vomiting in women receiving cyclophosphamide, methotrexate and 5-FU ( CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 66: 1601–1604

    PubMed  CAS  Google Scholar 

  46. Morrow GR (1982) Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients. JNCI 68: 585–588

    PubMed  CAS  Google Scholar 

  47. Morrow GR, Morrell C (1982) Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 307: 1476–1480

    Article  PubMed  CAS  Google Scholar 

  48. Kris MG, Gralla RJ, Clark RA et al. (1985) Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 3: 1379–1384

    PubMed  CAS  Google Scholar 

  49. Strum S, McDermed J, Abrahano-Umali R et al. (1985) Management of cisplatin (DDP)-induced delayed-onset nausea (N) and vomiting (V): preliminary results with two drug regimens. Proc Am Soc Clin Oncol 4: 263

    Google Scholar 

  50. Clark R, Kris M, Tyson L et al. (1986) Antiemetic (AE) trials to control delayed vomiting (V) following high-dose cisplatin (DDP). Proc Am Soc Clin Oncol 5: 257

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Solid Tumor Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    R. J. Gralla, M. G. Kris, L. B. Tyson & R. A. Clark

Authors
  1. R. J. Gralla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. G. Kris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. B. Tyson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. A. Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik C, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland

    Hans-Jörg Senn , Agnes Glaus (Oberschwester) & Luzius Schmid ,  (Oberschwester) & 

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin·Heidelberg

About this paper

Cite this paper

Gralla, R.J., Kris, M.G., Tyson, L.B., Clark, R.A. (1988). Controlling Emesis in Patients Receiving Cancer Chemotherapy. In: Senn, HJ., Glaus, A., Schmid, L. (eds) Supportive Care in Cancer Patients. Recent Results in Cancer Research, vol 108. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82932-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82932-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82934-5

  • Online ISBN: 978-3-642-82932-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation